Clinical Trials on Hematological Disease

Total 382784 results

West Virginia University

Completed

Effect of Body Mass on Acyclovir Pharmacokinetics

Hematological Malignancy | Pharmacokinetics of Acyclovir

United States
Hadassah Medical Organization

Withdrawn

Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host

Neoplasm Metastasis | Hematological Malignancy

Israel
Rigshospitalet, Denmark
Danish Cancer Society

Not yet recruiting

AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation (AlloCare)

Hematological Diseases

Denmark
Chia Tai Tianqing Pharmaceutical Group Nanjing...

Recruiting

Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors

Hematological Tumors

China
Zhejiang University

Not yet recruiting

Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies

Hematological Malignancies

China
Kangpu Biopharmaceuticals, Ltd.

Recruiting

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects

Hematological Malignancies

United States
Rhizen Pharmaceuticals SA

Completed

Compassionate Use Study of Tenalisib (RP6530)

Hematological Malignancies

United States, Georgia, Poland
medac GmbH

Completed

Dose-range Finding Treosulfan-based Conditioning

Hematological Malignancies

Germany, Finland, Poland, Sweden
Novartis Pharmaceuticals

Completed

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

Hematological Malignancies

Germany, Switzerland, France
Beijing Immunochina Medical Science & Technology...

Unknown

Safety and Efficacy Evaluation of IM19 Cells

Hematological Malignancies

China
Agennix

Withdrawn

Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies

Hematological Malignancies
Azienda Ospedaliera San Giovanni Battista

Completed

Nonmyeloablative Stem Cell Transplant in Elderly

Hematological Malignancies

Italy
University Of Perugia

Unknown

Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies

Hematological Malignancies

Italy
Assistance Publique - Hôpitaux de Paris
Pierre and Marie Curie University; Paris 12 Val de Marne University

Completed

Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation (ILD-TK01)

Hematological Malignancy

France
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Withdrawn

Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies

Transplant-Related Hematologic Malignancy

Spain
Esanex Inc.

Completed

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

Cancer

United States
Hutchmed

Recruiting

A Clinical Study of HMPL-506 in Patients With Hematological Malignancies

Hematological Malignancies

China
Miltenyi Biomedicine GmbH
City of Hope Comprehensive Cancer Center

Not yet recruiting

M-2018-334 in Hematological Malignancies (HAPLO2022)

Hematological Malignancies
Smart Immune SAS

Recruiting

Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide

Hematological Malignancies

France
Smart Immune SAS

Recruiting

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

Hematological Malignancies

United States
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

Hematological Malignancies

China
Gilead Sciences

Terminated

Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies

Hematological Malignancies

United States, United Kingdom
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)

Hematological Malignancies

United States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)

Hematological Malignancies

China
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Dutch...

Completed

MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT (PSCT19)

Hematological Malignancies

Netherlands
Wei Zhao
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Unknown

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Hematological Neoplasms

China
M.D. Anderson Cancer Center

Completed

Study of ABT-751 in Patients With Refractory Hematologic Malignancies

Hematological Malignancies

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

Hematological Malignancies

United States
University of Pavia
Fondazione Salvatore Maugeri; IRCCS Policlinico S. Matteo

Unknown

Molecular Disease Profile of Hematological Malignancies (RELab1)

Hematological Malignancies

Italy
Hospices Civils de Lyon

Unknown

Extracorporal Photopheresis Pilot Study (ECP)

Hematological Malignancies

France
General Hospital Groeninge

Completed

Central Venous Access Device Removal in Cancer Patients

Oncology | Haematological Malignancy

Belgium
University Hospital, Montpellier
Soroptimist association of Monaco

Recruiting

Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia (ALADIN)

Solid Tumor, Childhood | Pediatric Tumor | Familial Cancer | Hematological Tumor

France
Institut Paoli-Calmettes

Completed

A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation (ITAC02-01)

Solid Tumor | Hematological Malignancy | Allograft | Allogeneic Cell Transplantaion

France
Centre Francois Baclesse

Completed

Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy (TelOG)

Cancer | Hematologic Malignancy

France
The Affiliated People's Hospital of Ningbo University
UTC Therapeutics Inc.

Recruiting

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Lymphoma | Leukemia | Myeloma | Relapsed/Refractory Hematological Malignancies

China
Nottingham University Hospitals NHS Trust
Newcastle University; University of Kansas; Macmillan Cancer Support; Bishop Grosseteste...

Terminated

Nutrition Health Literacy of Cancer Patients and Their Support Networks. (NiiCproject)

Cancer | Oncologic Disorders | Nutrition Aspect of Cancer | Haematological Malignancy

United Kingdom
The University of Hong Kong

Recruiting

oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort

Cancer | Graft Vs Host Disease | Haematological Malignancy

Hong Kong
Albert Einstein College of Medicine

Recruiting

Hematology Biobank : Invitro Study of Blood Disorders

Hematological Disorders

United States
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological Malignancies

AML

China
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies

AML

China
Charite University, Berlin, Germany

Unknown

Exercise During Chemotherapy for Patients With Hematological Malignancies

Hematological Malignancies | Hematological Diseases

Germany
Assiut University

Not yet recruiting

Spectrum of Hematological Disorders in Pediatrics

Pancytopenia
Assiut University

Not yet recruiting

Characteristics and Outcomes of Patients With Hematological Malignancies

Haematologic Neoplasm
Children's Hospital of Fudan University

Recruiting

Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology (NiCE)

Solid Tumor | Hematological Malignancies

China
Rhode Island Hospital

Unknown

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

Solid Tumors | Hematological Malignancies

United States
First Affiliated Hospital of Zhejiang University

Recruiting

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Leukemia

China
Armando Santoro, MD

Completed

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Tumors | Hematological Neoplasms

Italy
University Hospital, Brest

Recruiting

Optical Genome Mapping in Hematological Malignancies (CARTOGEN)

MDS | ALL | Other Hematologic Malignant Neoplasms

France
Ospedale San Carlo Borromeo
Associazione Oncologica Milanese AmoLaVita ONLUS

Not yet recruiting

Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies

Cognitive Impairment | Chemo-brain | Haematological Malignancy

Italy
Novartis Pharmaceuticals

Completed

A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies

United States

Clinical Trials on Hematological Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations